Physician profile
Jeff M Arthur
NPI 1881669554
$6,611.11
in general payments reported to CMS, 2019-2025
30 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $811 · 2021: $794 · 2022: $810 · 2023: $821 · 2024: $1,149 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,066 · Travel and Lodging: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,066.02 |
| Travel and Lodging | $281.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,429.71 | 2019-2025 | Intracept, General - Pain Management, Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $619.43 | 2019-2025 | Relistor |
| Relievant Medsystems, INC. | $574.93 | 2021-2023 | Intracept |
| Saluda Medical Americas, INC. | $573.09 | 2023-2024 | Evoke Scs, Evoke |
| Spr Therapeutics, INC | $340.65 | 2023-2025 | Sprint Pns System |
| Stryker Corporation | $322.53 | 2021-2025 | Mild Device Kit |
| Si-Bone, INC. | $248.37 | 2019-2025 | |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $235.95 | 2023-2025 | V-Loc 180, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Intrinsic Therapeutics | $228.52 | 2024-2025 | Barricaid Acd (Annular Closure Device) |
| Stimwave Technologies Incorporated | $228.28 | 2019-2022 | |
| Vertiflex, INC. | $221.59 | 2019 | |
| Grt US Holding, INC. | $209.11 | 2022 | |
| Vertos Medical, INC. | $173.75 | 2020-2022 | |
| Globus Medical, INC. | $166.11 | 2025 | Senza, Vyrsa V1 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $162.02 | 2024 | Prospera |
| Nalu Medical, INC. | $129.25 | 2024-2025 | Nalu Neurostimulation System |
| Epimed International, INC | $89.66 | 2019 | |
| Abbvie INC. | $70.00 | 2025 | |
| Mml US, INC. | $64.18 | 2023 | Reactiv8 |
| Abbott Laboratories | $59.12 | 2020-2021 | |
| Nevro Corp. | $49.85 | 2024 | Senza |
| Pfizer INC. | $47.23 | 2020-2021 | |
| Medtronic USA, INC. | $28.16 | 2019 | |
| Painteq LLC | $22.31 | 2024 | Painteq |
| Pacira Pharmaceuticals Incorporated | $17.03 | 2025 | Exparel |
| Avanos Medical | $17.02 | 2025 | Standard Rf Disposables |
| Scilex Pharmaceuticals INC. | $15.42 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.09 | 2020 | |
| Horizon Therapeutics Plc | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.